FDA staff sets voting questions for Sarepta's muscle drug

(Reuters) - U.S. Food and Drug Administration staff on Friday formulated voting questions on Sarepta Therapeutics Inc's muscle wasting drug, ahead of a highly anticipated meeting of independent panel of experts on Monday to review the drug.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro